Insights from 2025 ASCO® GU Annual Meeting

 

Renal Cell Carcinoma
07:24

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Insights: Survival of Patients With mRCC With or Without Brain Metastases

FEATURING Michael Hurwitz
  • 28 views
  • April 2, 2025
06:10

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Insights: Updated Results of the TIDE-A Study Evaluating Avelumab + Intermittent Axitinib in Previously Untreated Patients With mRCC

FEATURING Chiara Ciccarese
  • 22 views
  • March 30, 2025
08:49

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: Immunogenomic Determinants of Exceptional Response to ICI in RCC - Data From CheckMate 214 and JAVELIN Renal 101

FEATURING Renee Maria Saliby
  • 31 views
  • March 19, 2025
20:17

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: The Future of Biomarkers in RCC

FEATURING Samra Turajlic
  • 37 views
  • March 10, 2025
08:48

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Insights: Association Between PD-1 Expression on Regulatory T Cells and Resistance to 1L Nivo in Advanced ccRCC - HCRN GU16-260 Trial

FEATURING Razan Mohanna
  • 7 views
  • March 7, 2025
10:38

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Insights: Efficacy Outcomes With Belzutifan vs. Everolimus by Baseline Disease Characteristics and Burden Subgroups - LITESPARK-005 Study

FEATURING Guillermo de Velasco
  • 36 views
  • March 4, 2025
20:24

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: Striving Toward New Frontiers in Clear Cell Kidney Cancer - Insights From Key Trials

FEATURING Tian Zhang
  • 114 views
  • March 4, 2025
04:05

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Insights: Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in mRCC - BOOST-RCC Study

FEATURING Tian Zhang
  • 13 views
  • March 4, 2025
06:56

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Insights: Final OS and ctDNA Data for Savolitinib + Durvalumab in Advanced Papillary Renal Cancer - CALYPSO Trial

FEATURING Francesca Jackson-Spence
  • 11 views
  • February 27, 2025
19:15

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: Biomarkers in RCC - Current State and Future Potential

FEATURING Simpa Salami
  • 145 views
  • February 26, 2025
24:13

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Insights: Efficacy and Safety of Nivo/Ipi in Metastatic Variant Histology RCC - A Retrospective Analysis From MD Anderson

FEATURING Mohammad Jad Moussa
  • 79 views
  • February 25, 2025
  • 2
09:45

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Summary: Adjuvant Therapy in RCC - A Practical Guide

FEATURING Laurence Albiges
  • 79 views
  • February 24, 2025
  • 2
14:47

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Insights: Cytoreductive Nephrectomy in mRCC - Perioperative Risk Characteristics in the Contemporary Era

FEATURING Shawn Dason
  • 19 views
  • February 21, 2025
12:11

Insights from 2025 ASCO® GU Annual Meeting

ASCO® GU 2025 Insights: Cabozantinib + Nivo + Ipi in 1L aRCC - Final Results of COSMIC-313

FEATURING Laurence Albiges
  • 65 views
  • February 20, 2025
  • 2